Five little-known diseases to watch out for in 2017
The phrase “emerging disease”, to describe an infectious disease that is new to humans or which is suddenly increasing its geographical...
top of page
Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO
bottom of page